Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1007/s00592-022-01989-7
Published Online: 2022-11-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Haiyan
Rao, Xiaosheng
Jia, Junya
Yan, Tiekun
Li, Dong http://orcid.org/0000-0001-9686-8813
Text and Data Mining valid from 2022-11-01
Version of Record valid from 2022-11-01
Article History
Received: 27 July 2022
Accepted: 25 September 2022
First Online: 1 November 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: Not applicable.